Get startedLog in
    Picture of Zynerba Pharmaceuticals logo

    ZYNE — Zynerba Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall Cap
    All News

    Brief: Zynerba Pharmaceuticals Reports Fourth Quarter And Full Year 2021 Financial Results And Operational Highlights

    Picture of Zynerba Pharmaceuticals logoZynerba Pharmaceuticals
    01/03/2022 12:13
    March 1 (Reuters) - Zynerba Pharmaceuticals Inc  ZYNE.O :
    * ZYNERBA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL
YEAR
2021 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
    * Q4 LOSS PER SHARE $0.22
    * CASH RUNWAY INTO SECOND-HALF 2023; $67.8 MILLION IN CASH
AND
CASH EQUIVALENTS AT DECEMBER 31, 2021
    * Q4 EARNINGS PER SHARE VIEW $-0.26 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXMSNWX 
Further company coverage:  ZYNE.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Zynerba Pharmaceuticals

    See all news